The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019.

ABSTRACT:

Aims

Recently, several therapeutic agents have decreased the progression to critical disease in patients with mild/moderate COVID-19. However, their use is limited to patients with ≥1 clinical risk factor. We aimed to evaluate echocardiographic features that may aid in risk stratification for patients with mild/moderate COVID-19.

Methods

278 consecutive patients with mild/moderate COVID-19 underwent prospective clinical and echocardiographic examination, ≤7 days of symptoms, as part of a predefined protocol. Analysis to identify echocardiographic predictors of outcome was performed.

Results

In the multivariable risk model, E/e', TAPSE, and pulmonary acceleration time (PAT) were associated with the composite outcome (p = 0.01, 0.005, 0.05, respectively). Stepwise analy

SUBMITTER: Lupu L 

PROVIDER: S-EPMC9533646 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature